This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| British Journal of Clinical Pharmacology | |
|---|---|
| Title | British Journal of Clinical Pharmacology |
| Discipline | Clinical pharmacology |
| Editor | Peter J. Smith |
| Publisher | Wiley-Blackwell on behalf of the British Pharmacological Society |
| Country | United Kingdom |
| History | 1974–present |
| Frequency | Monthly |
| Issn | 0306-5251 |
British Journal of Clinical Pharmacology The British Journal of Clinical Pharmacology is a peer-reviewed medical journal publishing research on drug action and therapeutics. It appears monthly and is affiliated with the British Pharmacological Society, engaging authors and readers from institutions such as University of Oxford, University of Cambridge, Harvard Medical School, Mayo Clinic, and Imperial College London. The journal communicates clinical trials, pharmacokinetics, pharmacodynamics, and pharmacogenomics to audiences including members of Royal College of Physicians, National Institute for Health and Care Excellence, World Health Organization, and regulatory agencies like the European Medicines Agency.
The journal was established in 1974 during a period of expansion in clinical sciences influenced by figures associated with National Health Service, Wellcome Trust, Medical Research Council, and universities such as King's College London and University College London. Early editorial relationships connected to societies including the British Pharmacological Society and editorial boards drawing from Guy's Hospital, St Thomas' Hospital, Addenbrooke's Hospital, and international centers like Johns Hopkins Hospital and Karolinska Institute. Over decades the journal navigated changes triggered by milestones such as the Declaration of Helsinki, the advent of guidelines from International Council for Harmonisation, and landmark trials at institutions like Cleveland Clinic and Vanderbilt University Medical Center.
The journal focuses on clinical pharmacology topics that intersect with organizations and initiatives such as Food and Drug Administration, European Society of Clinical Pharmacology and Therapeutics, American College of Clinical Pharmacology, and projects from Wellcome Trust and Bill & Melinda Gates Foundation. It aims to publish work on drug development stages involving collaborators at GlaxoSmithKline, AstraZeneca, Pfizer, Novartis, Roche, and academic groups from University of Edinburgh, University of Glasgow, University of Manchester, University of Southampton, and University of Bristol. The remit includes trials influenced by protocols similar to those at Massachusetts General Hospital, Brigham and Women's Hospital, Cedars-Sinai Medical Center, and studies referencing standards from Cochrane Collaboration and CONSORT.
Editorial leadership traditionally involves editors and associate editors affiliated with institutions such as University of Liverpool, University of Leeds, University of Birmingham, Monash University, and University of Melbourne. The peer review process engages reviewers from networks including European Medicines Agency, National Institutes of Health, Wellcome Trust Sanger Institute, and specialist groups at Children's Hospital of Philadelphia, Dana-Farber Cancer Institute, and Scripps Research. Editorial policies align with statements from Committee on Publication Ethics and best practice exemplars from The Lancet, New England Journal of Medicine, BMJ, and Journal of the American Medical Association.
The journal is indexed in major services and databases such as PubMed, MEDLINE, Scopus, Web of Science, and EMBASE. Bibliometric coverage is tracked by organizations like Clarivate Analytics and Elsevier, and citation data inform metrics alongside listings in directories maintained by Directory of Open Access Journals and catalogues used by libraries at British Library, Library of Congress, National Library of Medicine, and university systems at Yale University and Princeton University.
Impact and reception have been measured against journals including The Lancet, BMJ, New England Journal of Medicine, Nature Medicine, JAMA Oncology, and specialty outlets such as Clinical Pharmacology & Therapeutics and European Journal of Clinical Pharmacology. The journal's influence is discussed in analyses by think tanks and funders like RAND Corporation, King's Fund, and policy commentary in outlets associated with Financial Times and The Times. Citation trends reflect contributions from collaborative consortia including 1000 Genomes Project, Human Genome Project, European Molecular Biology Laboratory, and public health initiatives led by Centers for Disease Control and Prevention.
Notable publications have addressed pharmacogenetics with links to studies from Wellcome Trust Case Control Consortium, drug safety reports from Yellow Card Scheme, and consensus statements involving European Society of Cardiology and American Heart Association. Special issues have focused on topics in collaboration with conferences such as European Society of Cardiology Congress, American Society of Clinical Oncology Annual Meeting, International Congress of Pharmacology, and symposia organized by Royal Society and Royal Society of Medicine. Landmark articles have cited research from groups at Stanford University, University of California, San Francisco, Massachusetts Institute of Technology, and policy frameworks from World Bank and United Nations agencies.
The journal operates under a mixed publication model involving subscription access through publishers like Wiley-Blackwell and open access options compliant with mandates from funders such as Wellcome Trust, UK Research and Innovation, European Research Council, and transformative agreements negotiated with consortia like Jisc and university publishers at Oxford University Press and Cambridge University Press. Authors often have affiliations with research funders including National Institute for Health Research and charities like Cancer Research UK and may comply with licensing standards endorsed by Creative Commons and reporting expectations mirrored by Research Councils UK.
Category:Pharmacology journals